Standout Papers

Defining biochemical failure following radiotherapy with or without horm... 2000 2026 2008 2017 2.0k
  1. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference (2006)
    Mack Roach, Gerald E. Hanks et al. International Journal of Radiation Oncology*Biology*Physics
  2. Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate (2005)
    Anthony L. Zietman, Michelle DeSilvio et al. JAMA
  3. Bladder cancer (2009)
    Donald S. Kaufman, William U. Shipley et al. The Lancet
  4. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy (2000)
    Andy Trotti, Roger W. Byhardt et al. International Journal of Radiation Oncology*Biology*Physics
  5. Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09 (2010)
    Anthony L. Zietman, Kyounghwa Bae et al. Journal of Clinical Oncology
  6. Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02 (2003)
    Gerald E. Hanks, Thomas F. Pajak et al. Journal of Clinical Oncology
  7. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (1997)
    Miljenko V. Pilepich, Richard Caplan et al. Journal of Clinical Oncology
  8. Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer (2008)
    Eric M. Horwitz, Kyounghwa Bae et al. Journal of Clinical Oncology
  9. Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233 (2014)
    Raymond H. Mak, Daniel Hunt et al. Journal of Clinical Oncology
  10. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience (2017)
    Nicholas J. Giacalone, William U. Shipley et al. European Urology

Immediate Impact

5 by Nobel laureates 6 from Science/Nature 89 standout
Sub-graph 1 of 16

Citing Papers

Prostate Cancer
2025 Standout
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
37 intermediate papers

Works of William U. Shipley being referenced

Radiation Dose–Volume Effects of the Urinary Bladder
2010
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
2000 Standout
and 28 more

Author Peers

Author Last Decade Papers Cites
William U. Shipley 14000 9717 5384 399 23.4k
Anthony L. Zietman 10427 5398 3942 328 16.4k
M. Bolla 15983 4937 3216 226 22.0k
Robert Huddart 5498 7492 1979 384 14.4k
Paul F. Schellhammer 9270 3896 1095 268 17.2k
Alberto Briganti 15061 6704 887 1.0k 20.8k
David J. Grignon 16251 5161 1495 362 22.6k
Gerald E. Hanks 13721 3801 6512 390 19.0k
Steven Joniau 13786 3278 1087 440 17.8k
David P. Dearnaley 11095 4161 4502 410 17.9k
Jason A. Efstathiou 4892 4758 1728 309 11.0k

All Works

Loading papers...

Rankless by CCL
2026